# Atrial Fibrillation Trial to Evade Recurrence: effectS of Hiit Before electrO-Cardioversion for 3-weeKs

> **NCT03467633** · NA · TERMINATED · sponsor: **Ottawa Heart Institute Research Corporation** · enrollment: 12 (actual)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **BEHAVIORAL:** High-intensity interval training

## Key facts

- **NCT ID:** NCT03467633
- **Lead sponsor:** Ottawa Heart Institute Research Corporation
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-25
- **Primary completion:** 2020-10-08
- **Final completion:** 2020-10-08
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Not enough participants recruited.
- **Last updated:** 2020-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03467633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03467633, "Atrial Fibrillation Trial to Evade Recurrence: effectS of Hiit Before electrO-Cardioversion for 3-weeKs". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03467633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*